Smith MP - Search Results

1

Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease.

Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Makris M, et al. Among authors: smith mp. Thromb Haemost. 2002 Sep;88(3):387-8. Thromb Haemost. 2002. PMID: 12353065

2

Continuous infusion therapy with very high purity von Willebrand factor concentrate in patients with severe von Willebrand disease.

Smith MP, Rice KM, Bromidge ES, Lawn M, Beresford-Webb R, Spence K, Khair K, Hann I, Savidge GF. Smith MP, et al. Blood Coagul Fibrinolysis. 1997 Jan;8(1):6-12. doi: 10.1097/00001721-199701000-00002. Blood Coagul Fibrinolysis. 1997. PMID: 9105631

3

Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.

Smith MP, Ludlam CA, Collins PW, Hay CR, Wilde JT, Grigeri A, Melsen T, Savidge GF. Smith MP, et al. Thromb Haemost. 2001 Oct;86(4):949-53. Thromb Haemost. 2001. PMID: 11686351 Clinical Trial.

4

Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.

Smith MP, Spence KJ, Waters EL, Beresford-Webb R, Mitchell MJ, Cuttler J, Alhaq A, Brown SA, Savidge GF. Smith MP, et al. Thromb Haemost. 1999 Jan;81(1):35-8. Thromb Haemost. 1999. PMID: 9974371 Clinical Trial.

5

Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic study.

Norris LA, Bonnar J, Smith MP, Steer PJ, Savidge G. Norris LA, et al. Among authors: smith mp. Thromb Haemost. 2004 Oct;92(4):791-6. doi: 10.1160/TH03-10-0618. Thromb Haemost. 2004. PMID: 15467910

6

Real-time quantitative PCR analysis of factor XI mRNA variants in human platelets.

Podmore A, Smith M, Savidge G, Alhaq A. Podmore A, et al. J Thromb Haemost. 2004 Oct;2(10):1713-9. doi: 10.1111/j.1538-7836.2004.00924.x. J Thromb Haemost. 2004. PMID: 15456480 Free article.

7

The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway-based assays.

Moore GW, Smith MP, Patel Y, Savidge GF. Moore GW, et al. Among authors: smith mp. Blood Coagul Fibrinolysis. 2002 Apr;13(3):261-9. doi: 10.1097/00001721-200204000-00013. Blood Coagul Fibrinolysis. 2002. PMID: 11943941

8

The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.

Moore GW, Smith MP, Savidge GF. Moore GW, et al. Among authors: smith mp. Blood Coagul Fibrinolysis. 2003 Apr;14(3):307-12. doi: 10.1097/01.mbc.0000061283.28953.39. Blood Coagul Fibrinolysis. 2003. PMID: 12695757

9

Megakaryocytes and platelets in alpha-granule disorders.

Smith MP, Cramer EM, Savidge GF. Smith MP, et al. Baillieres Clin Haematol. 1997 Feb;10(1):125-48. doi: 10.1016/s0950-3536(97)80054-6. Baillieres Clin Haematol. 1997. PMID: 9154319 Review.

10

Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment.

Smith MP, Rice KM, Savidge GF. Smith MP, et al. Thromb Haemost. 1997 Feb;77(2):406-7. Thromb Haemost. 1997. PMID: 9157608 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters